Gunnar Brobert

机构：Bayer (Germany) · ORCID：0000-0002-7446-9851

发表论文 74 篇 · 总被引 1438 次 · h-index 22

代表论文

CODE-EHR best-practice framework for the use of structured electronic health-care records in clinical research (2022 · The Lancet Digital Health · 被引 76)
CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research (2022 · BMJ · 被引 49)
CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research (2022 · European Heart Journal · 被引 36)
Renal decline in patients with non-valvular atrial fibrillation treated with rivaroxaban or warfarin: A population-based study from the United Kingdom (2022 · International Journal of Cardiology · 被引 33)
Population-based study of long-term anticoagulation for treatment and secondary prophylaxis of venous thromboembolism in men with prostate cancer in Sweden (2022 · BMC Urology · 被引 27)
Effectiveness and Safety of Rivaroxaban and Low Molecular Weight Heparin in Cancer-Associated Venous Thromboembolism (2023 · JACC CardioOncology · 被引 21)